Liraglutide, long-acting GLP-1 agonist, has also been shown to induce significant weight loss and reduce SBP in a group of Asian patients [134]
Both medications effectively treat PCOS by improving insulin sensitivity
These medications, called GLP1 antigens, mimic the naturally occurring glucagon-like peptide 1 (GLP1) hormone
Neurologic symptoms, including developmental delays, cognitive disorders, and seizures, have also been observed (185, 186)
Aanvullende informatie De getoonde productafbeeldingen dienen uitsluitend ter illustratie en kunnen afwijken van het daadwerkelijk geleverde product
It was FDA-approved as Mounjaro for type 2 diabetes in May 2022 and as Zepbound for chronic weight management in November 2023